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ABSTRACT  We  used  cholera  toxin,  which  binds  exclusively  and  with  a  high  affinity  to  the 
ganglioside GM1, as a probe to investigate  the distribution  of this glycolipid  on the surface  of 
mouse  lymphocytes.  When  lymphocytes  are  incubated  with  cholera toxin  (or its  B subunit) 
and then sequentially with horse anti-toxin and  FITC-swine anti-horse Ig at 37°C, the cholera 
toxin-ganglioside  GM1 complex  is redistributed  to a cap at one pole of the cell. The capping 
of cholera toxin-GM1 complexes  is slower than the capping of surface-lg complexes,  requires 
two antibodies, and is inhibited at high toxin concentrations.  Cholera toxin-GM,  like surface- 
Ig capping,  is an  energy-dependent  process  and  is inhibited  by sodium  azide,  low tempera- 
tures, or cytochalasin B, but is unaffected by demecolcine. An affinity-purified antibody against 
~-actinin  was  used  to  examine  the  distribution  of  this  cytoskeletal  component  during  the 
capping  process.  88% of the cells  that  had a surface  Ig cap displayed  a co-cap of c~-actinin, 
and 57% of the cells  that had a cholera toxin-GM~ cap displayed a co-cap of c~-actinin. Time 
course studies  revealed similar kinetics of external ligand  cap formation  and the formation  of 
~-actinin  co-caps.  We  conclude  that capping of a cell-surface  glycolipid  is associated  with a 
reorganization  of the  underlying  cytoskeleton.  The  implications  of such  an  association  are 
discussed  in the context of current models of the mechanism of capping. 
Although improvements in analytical procedures have led to 
the characterization of a large number of new glycosphingo- 
lipids  in  animal  cells  in  recent years,  surprisingly little  is 
known about the function and organization of glycosphingo- 
lipids in membranes (1). The complexity of membrane gly- 
colipid profiles suggest that they are likely to fulfill other than 
a purely structural role, and evidence that glycolipids can act 
as  cell  surface  receptors  for Escherichia  coli  and  cholera 
enterotoxins, tetanus toxin, the glycoprotein hormones, inter- 
feron, macrophage migration inhibition  factor, fibronectin, 
and Sendai virus has been presented (reviewed in  reference 
1), although in some cases this has been disputed (2, 3). 
The conclusion that  the  high-affinity binding of cholera 
toxin to the cell surface is mediated by the sialic acid-contain- 
ing glycolipid ganglioside GM~ l is supported by a wide variety 
of experimental approaches,  including the  isolation  of the 
cholera toxin-ganglioside GMI complex from the surface of 
Ganglioside nomenclature is according to L. Svennerholm, 1963, £ 
Neurochem.  10:613-623. 
several  different cell types by immune  precipitation (4-6). 
Because of this, cholera toxin has been widely used as a probe 
to investigate the levels and organization of ganglioside  GM~ 
in membranes. Interestingly, binding of cholera toxin to lym- 
phocytes leads to the subsequent redistribution of the toxin- 
ganglioside GM~ complex to one pole of the cell, the so-called 
capping phenomenon (7,  8).  A similar response can be in- 
duced  with  anti-glycolipid  antibodies  (9).  Capping  of the 
toxin-ganglioside GMt  complex is  temperature dependent, 
requires energy, and is inhibited by cytochalasin B (7, 8). The 
results are analogous to those  obtained in  experiments on 
capping of surface Ig in lymphocytes (reviewed in reference 
10). 
Two main models have been proposed to explain the cap- 
ping of cell  surface receptors. Bretscher (11)  suggested  that 
there was a  directed flow of membrane lipids towards one 
pole of the cell, and that monomeric proteins could resist this 
flow by Brownian motion, whereas large cross-linked aggre- 
gates  would  he  swept  along  to  one  pole  of the  cell.  The 
alternative hypothesis proposes that the cross-linking of cell 
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ligand-receptor complex to the microfilament system, which 
then directs it to one pole of the cell (12).  This latter model 
is  supported  by experiments  that  show  that  capping  of a 
number of surface proteins is associated with co-capping of 
components of the microfilament system such as actin (13- 
15), myosin (15-17),  and  a-actinin (18-19).  In addition,  a 
detailed analysis of ligand-induced  redistribution  of surface 
Ig,  thymus  leukemia  antigen,  and  Fc  receptors  on  mouse 
lymphocytes showed that the kinetics of the capping process 
was essentially similar to that of the co-capping of myosin 
(17). These results appear to provide strong, though circum- 
stantial  evidence for a  direct involvement of the  microfila- 
ment  system  in  the  capping  of membrane  proteins.  The 
finding  that  Thyl  capping in  mouse  lymphocytes induces 
conversion of G  to F actin is also consistent with the above 
interpretation (20). 
No such evidence is available, however, to support the idea 
that the microfilament system is involved in ligand-induced 
capping ofglycolipids. In the present study, we have therefore 
attempted to clarify the role of the cytoskeleton in capping of 
membrane glycolipids by making a  detailed comparison of 
cholera toxin-ganglioside GM~ capping with that of surface Ig 
capping in mouse lymphocytes. In particular, we have com- 
pared the distribution of a-actinin in cells exhibiting cholera 
toxin-ganglioside GM~ caps with those displaying surface Ig 
caps. 
MATERIALS  AND  METHODS 
Preparation and Characterization  of an Affinity-purified  An- 
tibody against a-Actinin:  a-Actinin  was isolated from chicken gizzard 
as  described  by  Feramisco  and  Burridge  (21), and  further  purified  using 
preparative SDS PAGE (22) followed by electroelution (23). An antibody to a- 
actinin  was produced  in rabbits by subcutaneous  injection  of 500 ug of the 
purified  protein  in  Freund's complete  adjuvant,  followed by intramuscular 
injections of the same dose in incomplete adjuvant. Injections were repeated at 
2 l-d  intervals  until  an antibody  was detectable  using a  solid  phase  radio- 
immune assay. A crude  Ig fraction  of the  antiserum  was then  prepared  by 
ammonium sulphate precipitation, and pure antibodies to a-actinin  isolated by 
affinity  chromatography  on  a  l-ml  column  of Sepharose  4B  (Pharmacia, 
Hounslow, Middlesex, England) coupled with a-actinin  (0.5 mg of protein per 
ml of Sepharose). Bound IgG was eluted with 0.1  M glycine pH 2.8 (24). 
The affinity-purified  antibody  was characterized  by immunoblotting (25) 
and  found  to be  monospecific  for both chicken  and  mouse a-actinin.  The 
antibody  also (a) specifically immune precipitated  a-actinin  from  detergent 
extracts of ['S]methionine-labeled  BALB/c 3T3 mouse fibroblasts, (b) stained 
only the Z-line of murine myofibrils, and (c) stained the microfilament bundles 
of BALB/c 3T3 cells in the characteristic punctate manner, with concentrations 
near the membrane described by Lazarides and Burridge (26). 
Other Antibody Preparations:  Horse anti-cholera toxin was a gift 
from Dr. R. O. Thomson, Wellcome Research Laboratories, Beckenham, Kent, 
England. Rabbit  anti-cholera  toxin  was prepared  as previously described (4). 
Fab2 fragments of the rabbit anti-toxin  were prepared  by pepsin digestion of 
the IgG fraction followed by protein A-Sepharose (Sigma Chemical Co., Poole, 
Dorset, England) affinity chromatography  (27). SDS PAGE of the preparation 
showed that it contained no detectable intact Ig heavy chains. 
Fluoreseein-labeled Fab2 fragments of affinity-purified goat anti-rabbit  IgG 
was a gift from R. Sutherland,  Imperial Cancer  Research Fund Laboratories, 
London, England. The IgG fraction of a goat anti-rabbit  IgG (Miles Laborato- 
ties, Slough, Bucks, England) was labeled with tetramethyl  rhodamine  isothio- 
cyanate (Miles Labs) according to the method of Brandtsaeg (28), and affinity- 
purified on a rabbit Ig-Sepharose column (1.8 mg protein per ml of Sepharose) 
as described previously. 
Cells:  2- to 3-mo-old C57BL mice were sacrificed by cervical dislocation 
and the inguinal, axillary, and mesenteric lymph nodes were excised and pooled. 
The lymph nodes were gently teased apart  in ice-cold PBS/BSA  2 to produce a 
Z  Abbreviations  used  in  this paper:  BSA,  bovine  serum  albumin; 
cAMP,  3',5'-cyclic  adenosine  monophosphate;  DMSO,  dimethyl 
sulfoxide;  FITC,  fluorescein  isothiocyanate;  NP40,  Nonidet  P-40; 
PBS, Dulbecco's complete phosphate-buffered saline. 
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single cell suspension  of lymph node  lymphocytes,  which was then washed 
three  times  in  PBS containing  0.1% BSA and 5 mM glucose, and the  cells 
suspended to a concentration  of 2 x  10  7 cells/ml in ice-cold PBS/BSA. This 
procedure  results in a suspension  of cells with a viability of >90%  of which 
>94% are small or medium lymphocytes (29). 
Immunofluorescent  Staining of Cells:  Cholera toxin (Schwarz- 
Mann, Becton Dickinson, Wembley, Middlesex, England) was bound to lym- 
phocytes by incubating 0.1  ml of a cell suspension (2 ×  106 ceils in PBS/0.1% 
BSA) with  100  ng/ml cholera  toxin  for 30  min on ice. After washing three 
times  in  PBS/BSA, the  cells were  incubated  with  horse  anti-cholera  toxin 
(diluted  1:10) followed by a  1:50 final dilution  of a  fluorescein-labeled IgG 
fraction of a swine anti-horse  Ig (Nordic  Immunological  Labs, Maidenhead, 
England).  Incubations  were for  30  min on  ice, with  three  washes between 
incubations. Both antisera were diluted with an equal volume of normal mouse 
serum at least  1 h before use. The cholera toxin-antibody  complex was then 
capped  by raising the  temperature  to 37"C for the times  specified, and the 
process stopped by adding 2 volumes of ice-cold PBS/BSA. 50 ul aliquots were 
plated onto ice-cold coverslips and the cells allowed to attach to the glass for 5 
min at 4"C. The cells were then fixed in 3.8% formaldehyde in PBS for 30 min 
at room temperature.  At this stage, the cells could either be examined directly 
by mounting coverslips in PBS/50% vol/vol glycerol, or treated for the visual- 
ization of a-actinin. 
Redistribution  of membrane-bound lgG  was erected  by incubating  cells 
with a  1:40 dilution  of a fluorescein-labeled IgG fraction of a goat anti-mouse 
Ig (Nordic) for 30 min on ice, washing, then raising the temperature to 37"C. 
For visualization  of a-actinin,  the  fixed cells were washed thoroughly  in 
PBS, rinsed briefly in 0.1  M glycine in PBS, and extracted for 5 min in 0.2% 
vol/vol  Triton  X-100  in  PBS. After thorough washing, the  coverslips were 
overlaid sequentially with 50 #g/ml of the  rabbit  anti-c~-actinin in PBS/BSA 
then  100 ug/ml of an affinity-purified, rhodamine-labeled  goat anti-rabbit  Ig, 
with extensive washing between incubations. The coverslips were washed for 1 
h in repeated changes of PBS/BSA, mounted in PBS/glycerol, and examined 
using a Zeiss Standard  16  microscope equipped  with epifluorescence. Photo- 
graphs  were taken  on  llford  HP5  400  ASA  film. Quantitative  results were 
obtained by examining the fluorescence distribution on at least 150 cells directly 
from the microscope slides. These counts were confirmed using photographs of 
random fields of view. 
Identification of the Receptor  for Cholera  Toxin on Mouse 
Lymphocytes:  The  cholera  toxin  receptor  in  these  cells was  partially 
characterized  by  an  adaptation  of the  method of Burridge (30), exactly as 
described previously by us (5). Briefly, lymphocyte whole cell protein  (75 ug 
per track) was run in a 7.5% SDS-polyacrylamide gel, and after fixation the gel 
was overlaid with  ~2~I-labeled cholera toxin.  After extensive washing, the  gel 
was dried, and bound toxin was detected by autoradiography. 
RESULTS 
Identification of the Cholera Toxin  Receptor in 
Mouse Lymphocytes 
We have previously provided extensive evidence that the 
cholera toxin  receptor in  BALB/c  3T3  cells  and  a  mouse 
lymphoid cell  line is exclusively glycolipid in  nature (4,  5). 
To establish that this was also true for normal mouse lym- 
phocytes, cell proteins were resolved in SDS polyacrylamide 
gels, and the gels were overlaid with ~25I-labeled  cholera toxin. 
Fig.  1 shows that cholera toxin bound only to material run- 
ning at the dye front where we have previously shown glyco- 
lipids to travel (4), and there was no evidence for binding to 
any of the cellular proteins. This binding was totally elimi- 
nated when the gel was overlaid with  ~25I-labeled toxin that 
had been preincubated with ganglioside GM~  (Fig.  l c), and 
when the gel was first overlaid with nonradioactive toxin (data 
not shown), confirming the specificity of the labeling proce- 
dure.  The result  is  consistent with  the  conclusion  that  the 
cholera toxin  receptor in  mouse lymphocytes is exclusively 
glycolipid in nature. 
Capping of Cholera Toxin  in Mouse Lymphocytes 
Cholera toxin binding to mouse lymphocytes was visualized 
using a double antibody technique as described in the Mate- 
rials and Methods. After binding the toxin and antibodies to FIGURE  1  Identification  of  cholera  toxin  binding  molecules  in 
mouse  lymphocytes.  Total cellular proteins  (150  /~g/track) were 
resolved  in  7.5% SDS polyacrylamide gels, and the cholera toxin 
binding components identified by overlaying gel tracks with  ~2Sl- 
labeled toxin (3  x  106 cpm  in 0.75  ml  of PBS/0.1%  BSA specific 
activity 22  /~Ci/~g)  in  conjunction with  autoradiography, as  de- 
scribed in Materials and Methods. (a) Coomassie Blue-stained total 
cell protein. (b) Track overlaid with ~251-1abeled  cholera toxin. (c) As 
in Fig. 2 b, except the 12Sl-labeled  cholera toxin was preincubated 
with 50/~g/ml of bovine brain mixed gangliosides (Sigma Chemical 
Co., Poole, Dorset,  England) for 1 h at 0°C. 
cells kept on ice, the toxin was distributed as small aggregates 
or  patches  over the  surface  of the  cell,  (Fig.  2  a  and  b). 
However, when the cells were subsequently incubated at 37"C 
for 30 min, many of the cells displayed an accumulation of 
toxin at one pole of the cell, the so-called capping phenome- 
non  (Fig.  2  c and  d).  Capping of surface Ig in  response to 
anti-mouse  lg  is  shown  for  comparison  (Fig.  2  e  and f). 
Cholera toxin could be capped only when the double antibody 
method was used. If  the toxin was bound at 0*C, and the cells 
incubated at 370C for 30 min before fixation and the subse- 
quent addition of the two antibodies, there was no evidence 
of any  redistribution,  and  the  toxin  was  found  uniformly 
distributed over the cell surface (Fig. 2 g). When both cholera 
toxin and the anti-toxin were bound and the cells incubated 
at  37°C,  then  fixed before addition  of a  fluorescent second 
antibody,  capping  also  failed  to  occur  although  there  was 
evidence of patching in many of the cells (Fig. 2 h). 
To  check  the  specificity of the  antibodies  used,  cholera 
toxin was omitted from the  system and the cells incubated 
with the two antibodies alone. No detectable fluorescence was 
observed, showing that the antibodies were not cross-reacting 
with any molecules on the lymphocyte cell surface (Fig.  2 i). 
The possibility that the toxin-antibody complex was capping 
through interaction of the antibodies with the Fc receptor was 
excluded,  since the toxin  could be capped using Fab2  frag- 
ments of a  rabbit anti-cholera toxin plus FITC-labeled Fab2 
fragments of an affinity-purified goat anti-rabbit Ig (Fig. 2 j). 
Agents that disrupt microfilament organization (cytochal- 
asin B), or the energy supply of the cell (sodium azide), were 
potent  inhibitors  of cholera  toxin  capping at  all  the  times 
investigated (Fig.  3). Conversely an inhibitor of microtubule 
organization, demecolcine, was totally ineffective, but inter- 
estingly led to much brighter and more distinct caps. Quan- 
titative  analysis  showed  that  each  of these  agents  affected 
cholera toxin capping in a manner similar to Ig capping (data 
not shown). The results confirm earlier observations of other 
workers (8),  and  point to the  involvement of the microfila- 
ment system in capping of the cholera toxin-ganglioside GM1 
complex. 
Comparison of the Kinetics of Cholera Toxin 
Capping with Ig Capping 
The capping of cholera toxin occurred only at concentra- 
tions between 0.01  gg/ml and 0.2 ~g/ml. Below 0.01  ~g/ml 
of toxin the level of fluorescence fell below detectable limits. 
Interestingly above 0.2 #g/ml there was a  marked reduction 
in capping of the toxin, an observation previously reported 
by Revesz and Greaves (8). Binding of cholera toxin through 
its  B-subunit to  cell  surface ganglioside  GM~  subsequently 
leads to activation of adenylate cyclase by the A-subunit of 
the toxin  (31).  We therefore considered the  possibility that 
the  above  phenomenon  was  a  consequence  of a  massive 
increase in intracellular levels of cAMP produced when high 
concentrations of the toxin were used.  This possibility was, 
however, excluded by the observation that capping of cholera 
toxin B-subunit alone was also markedly reduced at higher 
concentrations (data not shown). 
The rate of cholera toxin capping was slow compared with 
Ig capping (Fig.  4). Over 90% of cells within the population 
were able to bind toxin.  Capping was maximal after 30-40 
rain, but only 50-60%  of positively stained cells exhibited a 
cap of  bound toxin. In contrast only 50% of  the cells displayed 
surface Ig, but of these 80-90% were able to form caps within 
7-10 min. Capping of cholera toxin B-subunit showed iden- 
tical kinetics to the intact toxin, again excluding the possibility 
that elevated levels of cAMP were reducing the rate of cap- 
ping.  The  slow  rate  of toxin  capping  was  also  apparently 
unrelated to the  need for a  double antibody layer since the 
kinetics of surface Ig capping was the same using a single or 
double antibody technique (Fig. 4). 
The Influence of Cholera Toxin Capping on 
Cytoskeletal Organization 
It has recently been shown that the patching and capping 
of a  number of cell  surface proteins is accompanied by co- 
patching  and  co-capping of a-actinin  (18,  19). The  result 
provides additional evidence for a role of the cytoskeleton in 
redistribution of components in the plane of the membrane. 
Since cholera toxin bound to the cell surface through a lipid, 
ganglioside GM~, can  also be capped, we further examined 
the  role of the cytoskeleton in  this process by investigating 
the  distribution  of a-actinin  in  cells  following  capping  of 
bound  toxin.  For  comparison the  distribution  of a-actinin 
with respect to surface Ig caps was also investigated. 
Lymphocytes incubated with anti-mouse Ig at 0°C showed 
substantial redistribution of surface Ig into patches whilst the 
a-actinin remained diffusely distributed around the cell  pe- 
riphery,  although  there  was  some  evidence  of co-patching 
(data  not  shown).  Incubation  of cells  at  37°C  for  7.5  min 
resulted in capping of surface Ig and in the majority of such 
cells, the a-actinin was concentrated directly under the cap of 
surface Ig, (Fig.  5 a  and b). Similarly incubation of iympho- 
cytes with cholera toxin and the double antibody layer at 0*C 
resulted  in  patching  of the  toxin  and  a  diffuse  peripheral 
staining of a-actinin.  Cells that had been incubated at 37"C 
for 30 min before visualization of a-actinin showed capping 
of the  toxin  and  in  many  cases  the  c~-actinin  was  again 
concentrated  under  the  caps  of membrane-bound  cholera 
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surface  Ig  and  cholera  toxin  bound  to 
mouse  lymphocytes.  (a-d)  Cholera  toxin 
(100  ng/ml),  horse  anti-toxin  (1:10), and 
FITC-labeled swine anti-horse Ig (1:50) were 
bound to  cells  at  0°C,  with  washing  be- 
tween each step. Cells were then incubated 
for 30 rain at 0*C (a and b) or 37°C (c and 
d). Fluorescence and phase contrast micro- 
graphs of the same fields of view are shown. 
(e-D FITC-labeled goat anti-mouse Ig (1:40) 
was bound to cells at O°C, and the temper- 
ature raised to 37~C for 7.5 min. Cells were 
examined by  fluorescence  (e)  and  phase- 
contrast  (/)  microscopy.  (g)  Cholera toxin 
(100  ng/ml)  was  bound at  0°C,  the  cells 
washed  and  subsequently  incubated  at 
37°C for 30 min, before fixation. Horse anti- 
toxin and  FITC-labeled swine anti-horse Ig 
were then sequentially bound at 20°C. (h) 
Cholera toxin  and  horse  anti-toxin  were 
bound at O°C, and the cells then incubated 
at 37°C for 30 min.  Following fixation cells 
were stained with FITC-labeled swine anti- 
horse  Ig. (i) Cells were treated as in c but 
with the omission of cholera toxin. (j) Cells 
were  incubated sequentially with  cholera 
toxin,  Fab2 fragments  of  rabbit  anti-toxin 
(1.5 mg/ml), and Fab2  fragments of affinity- 
purified  FITC-labeled  goat  anti-rabbit (50 
pg/ml) at 0°C for 30 min each, with washing 
between each step. Cells were then incu- 
bated  at  37°C  for 30  min.  Bar, 10 pm.  × 
1,000. 
toxin, (Fig. 5 c and d). The specificity of  the a-actinin staining 
was  confirmed  by substituting  the  affinity-purified anti  a- 
actinin with nonimmune Ig (Fig.  5 e and f) and preabsorbing 
the antibody with a-actinin (Fig.  5 g and h). 
Quantitative analysis of the  results showed that >89%  of 
Ig-positive cells displayed a cap after incubation with fluores- 
cent anti-mouse lg for 7.5 min at 37"C. Of the cells with an 
Ig cap,  ~88%  also  showed  an  exact  co-distribution  of a- 
actinin.  That  is,  in  only a  small percentage (12%)  of cells 
displaying an Ig cap was there no co-distribution of a-actinin. 
In the case of cholera toxin, ~62% of positively stained cells 
displayed a cap of bound toxin after incubation for 30 min at 
37°C. Of the cells with a cholera toxin cap ~ 57% also showed 
an  exact  co-distribution  of a-actinin.  Similar  results  were 
obtained when B-subunit was used in place of  the intact toxin. 
If the  redistribution  of surface Ig and  the  cholera toxin- 
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receptor complex is  directly related to the redistribution  of 
the  cytoskeletal  protein  a-actinin,  the  kinetics  of the  two 
events should be identical. Fig.  6 a shows the time course of 
surface Ig capping and the formation of co-incident a-actinin 
caps in an experiment carried out at 20"C to decrease the rate 
of capping and thus improve the accuracy of the analysis. The 
kinetics of surface Ig capping were almost exactly paralleled 
by  that  of a-actinin  co-capping.  Essentially  similar  results 
were obtained in experiments with cholera toxin (Fig. 6 b). In 
both cases the number of cells displaying an a-actinin cap in 
the absence of ligand also increased with time, but the rate of 
this so-called spontaneous a-actinin cap formation was much 
slower than that observed in the presence of added ligand. 
DISCUSSION 
We  have shown  that  cholera  toxin  or  the  toxin  B-subunit 80r  100 
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FIGURE  3  Effect of inhibitors of cytoskeletal function on the kinet- 
ics  of capping of bound cholera toxin. Cholera toxin (100 ng/ml), 
horse anti-toxin, and FITC-labeled swine anti-horse were bound at 
0°C as described in Fig. 2, and the cells then incubated at 37°C for 
30  min.  Binding  and  the  subsequent  incubations  at  37°C  were 
performed  in  the  presence  of  the  appropriate  inhibitors.  O,  no 
addition. F-I, plus  10  mM  NAN3.  &,  plus  20 /~g/ml  cytochalasin  B 
(stock solution 2 mg/ml in dimethyl sulfoxide (DMSO). Final DMSO 
concentration  1%. @,  1% DMSO  alone, x, plus  10  -4 M  demecol- 
cine. II, plus 10  -4 M  demecolcine and 20 ~,g/ml cytochalasin B. 
when  bound  to  the  surface of mouse  lymphocytes can  be 
induced  to cap by the addition  of anti-toxin followed by a 
second antibody. We were, however, unable to demonstrate 
capping  of bound  toxin  without  the  addition  of the  two 
antibodies, in contrast to the results of Craig and Cuatrecasas 
who  used  FITC-labeled  cholera  toxin  and  rat  mesenteric 
lymph  node  cells  (7).  Similar difficulties in  capping toxin 
alone have been experienced by others (32), and the discrep- 
ancy  remains to  be  explained,  although  it  may be due  to 
differences in the surface density of GMI among various cell 
types (8). Although we have not investigated the structure of 
the cholera toxin  receptor in  mouse lymphocytes in  detail, 
our results are consistent with it being a glycolipid, presumed 
to be ganglioside GMI, as in all other systems studied so far 
(4-6,  31).  Because  binding  of cholera  toxin  to ganglioside 
GM~ has a high affinity (Ko  ~  10  -1° M) and is thought to be 
essentially irreversible, we assume that the  capping process 
actually  involves  a  toxin-ganglioside  GMI  complex.  This 
interpretation  is supported by the  observation that the  low 
levels of binding of cholera toxin to human acute leukemia 
cells can be markedly increased by preincubation of the cells 
with ganglioside GM~, and that addition of a double antibody 
layer subsequently leads to capping (8). Capping of  the cholera 
toxin-ganglioside GM~ complex was not observed when cells 
were incubated at high concentrations of the toxin even in 
the presence of a  double antibody layer. The phenomenon 
has previously been reported by Revesz and Greaves (8), who 
found that  it was only exhibited by cells displaying a  high 
number of toxin binding sites. The significance of the obser- 
vation remains unclear. 
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FIGURE  4  Kinetics of capping of surface Ig and cholera toxin bound 
to  mouse  lymphocytes. All  ligands were  bound  at 0°C,  and  the 
temperature raised to 37"C for the times indicated. After fixing, the 
number  of  cells  displaying  a cap  was  counted.  The  results  are 
expressed  as  a  percentage  of the  ligand-positive cells.  @,  FITC- 
labeled goat anti-mouse Ig (1:40 dilution). A,  Rabbit anti-mouse Ig 
(1:30) followed by FITC-labeled goat anti-rabbit Ig (1:50). CI, Cholera 
toxin  (100  ng/ml)  followed  by  horse  anti-toxin  (1:10)  and  FITC- 
labeled swine anti-horse Ig (1:50). II, Cholera toxin B subunit (100 
ng/ml) followed by horse anti-toxin (1:10) and  FITC-labeled swine 
anti-horse Ig (1:50). 
The rate of capping of the cholera toxin-ganglioside GM1 
complex was slower than that of surface Ig capping. This was 
not simply due to the relatively large toxin-double antibody 
complex moving more slowly in the plane of the membrane, 
since surface Ig capped at about the same rate whether a single 
or a double antibody layer was used. There was no reduction 
in the number of observable cholera toxin-ganglioside GM1 
caps up to 1 h after raising the temperature to 37"C, whereas 
surface Ig caps had been largely removed by this time, pre- 
sumably by endocytosis (33).  Interestingly, it has been  re- 
ported that other cell surface molecules such as histocompat- 
ibility antigens, which cap comparatively slowly and require 
a double antibody layer to induce capping, also remain on 
the cell surface much longer than surface-Ig complexes (34). 
Antibody-induced  capping  of  cholera  toxin-ganglioside 
GM1 was inhibited by low temperature, azide, and an inhib- 
itor of microfilament but not microtubule organization. These 
results are essentially similar to those reported by Revesz and 
Greaves (8) who also used a double antibody system to induce 
capping of bound toxin, but differ from those of Craig and 
Cuatrecasas  (7)  who  found  that  capping of bound  FITC- 
labeled cholera toxin was more sensitive to agents that disrupt 
microtubule rather than microfilament organization. 
As the effects of the  above treatments on cholera toxin- 
ganglioside  GMI  capping  were  exactly  comparable  to  the 
effects on surface Ig capping, we decided to extend the com- 
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cholera toxin bound to mouse lymphocytes.  Surface Ig was capped 
by binding FITC-labeled  goat anti-mouse Ig, at 0°C, followed by 
incubation at  37°C  for  7.5  min.  Cholera toxin  was  capped  by 
binding toxin, horse anti-toxin, and  FITC-labeled swine anti-horse 
Ig at O°C, followed by incubation at 37°C for 30 min. After capping 
the cells were fixed, permeabilized, and stained with rabbit anti-a- 
actinin (50 #g/ml) and rhodamine-labeled  goat anti-rabbit Ig. Paired 
micrographs  show  FITC-labeled  ligand  (left  column)  and  rhoda- 
mine-labeled a-actinin (right column).  (a and b) Three lymphocytes 
bearing capped Ig (a) and co-caps of a-actinin (b). (c and d) A group 
of six lymphocytes bearing cholera toxin caps (c), five of which 
show co-caps of a-actinin (d). (e and  /)  Cells  bearing  Ig caps (e) 
stained with the rabbit IgG fraction which did not bind to the a- 
actinin affinity column (D. (g and h) Cells bearing cholera toxin caps 
(g) stained with anti-a-actinin preadsorbed  with 100/~g/ml a-actinin 
(h). e-h  clearly establish the specificity of the staining  procedure 
for a-actinin. The brightly fluorescent  particles  seen in  h do not 
coincide with cells and  are presumably  immune complexes.  Bar, 
10 #m. x  1,000. 
parison of the two processes further. Capping of surface Ig in 
lymphocytes is accompanied by the co-capping of actin (14, 
15),  myosin  (15-17)  and  a-actinin  (18,  19). We  chose  to 
investigate the possible association of a-actinin with cholera 
toxin-ganglioside GM~ caps because a-actinin is (a) thought 
to be concentrated at the internal face of the plasma mem- 
brane (35),  (b) can be demonstrated to co-cap with surface Ig 
using conventional  immunofluorescent techniques  (18-19), 
and (c) has been shown to co-cap with ligand-induced caps of 
a variety of other surface components in mouse lymphocytes 
such as Thy- 1 antigen (19), H2 antigen (18), and concanavalin 
452  T,E JOURNAL  OF  CELL BIOLOGY  '  VOLUME  97,  1983 
A  receptors  (18).  We  found  clear  evidence  that  antibody- 
induced caps of surface Ig and cholera toxin-ganglioside GM~ 
were associated with co-caps of a-actinin. However quantita- 
tive analysis showed that less cholera toxin-ganglioside GM~ 
caps were associated with an  a-actinin co-cap than was the 
case with surface Ig. Nevertheless >50% of the cells displaying 
a toxin-ganglioside GM~ cap showed co-capping of a-actinin. 
The  kinetics  of antibody-induced  cap  formation  for  both 
cholera toxin-ganglioside GMI and surface Ig was paralleled 
by the rate of formation of a-actinin co-caps, and there was 
little or no increase in a-actinin cap formation in the absence 
of added  ligand.  In  addition,  treatments  (low temperature, 
azide, and cytochalasin B) that inhibited capping of  the surface 
components also inhibited  the formation of a-actinin caps. 
The results show that  the  redistribution  of a-actinin  is  not 
only associated with capping of surface Ig as previously re- 
ported, but also with the capping of the cholera toxin-ganglio- 
side GMj complex. 
Despite  intensive  efforts,  details  of the  molecular events 
involved in the capping process are not understood. Based on 
a series of  elegant experiments, Braun et al. (17) have proposed 
that capping of lymphocyte surface molecules can be divided 
into two classes. They found that surface Ig, thymus leukemia 
antigen, and Fc receptors cap rapidly upon binding of a single 
ligand,  and  capping in  these  cases was associated with  co- 
capping  of myosin.  In  contrast  capping  of H2  and  Thy-I 
antigens was slow, only occurred if a double antibody system 
was used, and was not accompanied by co-capping of myosin. 
It was hypothesized that the first type of capping involved a 
ligand-induced reversible link between the surface component 
and the microfilament system, which then directed the com- 
plex to one pole of the cell.  It was proposed that the second 
type of capping was due to the formation of large cross-linked 
aggregates at the cell surface that subsequently fused into caps 
as a result of some other event, such as cell motility or directed 
flow of membrane lipid (11). 
Whilst the idea that membrane proteins can be directly or 
indirectly linked  to the  cytoskeleton has widespread  appeal 
(12,  36-38) the  idea of two different classes of capping has 
been disputed.  Firstly capping of H2 and  Thy-1  antigens as 
well  as  concanavalin  A  receptors  has  been  shown  to  be 
associated with the co-capping of a-actinin (18,  19) or actin 
(13) by other workers. Secondly it has recently been claimed 
that given optimal conditions,  all  ligands able to cross-link 
surface components will  induce capping at a  rate similar to 
that of surface Ig (39).  It is also difficult to accommodate our 
own results on capping of the cholera toxin-ganglioside GM~ 
complex into  the  above proposal.  The  capping is slow,  re- 
quires two antibodies  yet is  clearly associated in  many in- 
stances, with the co-capping of a-actinin. It should be noted 
however, that quantitative analysis revealed that many caps 
of cholera toxin-ganglioside GM~ had no apparent a-actinin 
subcap. Reference to the data on co-capping of myosin with 
surface Ig, thymus leukemia antigen, and Fc receptors show 
similar discrepancies (17),  making the interpretation of this 
type  of experiment  less  clearcut  than  might  appear when 
photographic evidence alone is presented ( 12-16,  18,  19). 
If  the microfilament system is responsible for the antibody- 
induced capping of the cholera toxin-ganglioside GM~ com- 
plex as our co-capping experiments would suggest,  the inter- 
action must be indirect since the hydrophobic region of the 
glycolipid is not thought to span the membrane. At present 
little is known about the organization of glycolipids in mem- 'o01 
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FIGURE  6  Comparison of the kinetics of capping with that of the formation of a-actinin co-caps. (A) Antibody-induced capping 
of surface Ig. Following binding of FITC-labeled goat anti-mouse Ig to cells at 0°C, cells were incubated at 20°C, instead of 37°C 
to reduce the  rate of the capping process. O, Cells with  a cap of surface  Ig. &,  Cells with  an  Ig cap that also displayed an ~- 
actinin co-cap. Both are expressed as a percentage of Ig-positive cells. I  Cells displaying an a-actinin cap in the absence of anti- 
mouse Ig. This so-called spontaneous a-actinin cap formation is expressed as percentage of cells staining positively for o~-actinin. 
(B) Antibody-induced  capping of bound cholera toxin. O, Cells with a cholera toxin cap. &, Cells with a cholera toxin cap that 
also displayed an ~-actinin co-cap. Both are expressed as a percentage of toxin-positive cells. I,  Cells displaying an a-actinin cap 
in the absence of bound toxin, expressed as a percentage of cells staining positively for a-actinin. 
branes  (1).  Preliminary  evidence  that  a  specific glycolipid 
could be cross-linked to  an  erythrocyte membrane protein 
has been presented (40),  and a low molecular weight amphi- 
pathic  protein  with  Paul  Bunnell  antigen  activity  isolated 
from bovine erythrocytes, has been shown to have a specific 
affinity for ganglioside GM3 (41).  Interestingly, we have re- 
cently found that cholera toxin-ganglioside GM~  complexes 
remain associated with the Triton X-100 insoluble cytoskel- 
eton of BALB/c 3T3  cells,  although the molecular basis of 
the observation remains unexplained (42). Similar results have 
been obtained by others (43),  and Sayhoun et al. (44)  have 
provided  some evidence  that  the  cholera  toxin-ganglioside 
GM,  complex isolated  from rat  erythrocytes by extraction 
with Triton X- 100 at 37°C is associated with cellular proteins, 
possibly of cytoskeletal origin. 
Arguments against a direct involvement of the microfila- 
ment system in the capping process have also been presented. 
Stern  and  Bretscher  (45)  found  that  Forssman  antigen  (a 
glycolipid) inserted into the plasma membrane of a number 
of cell lines lacking the antigen, could be induced to cap using 
a  double  antibody  system.  Capping  of the  glycolipid  was 
inhibited by dinitrophenol  and cytochalasin B, but not col- 
chicine. Exactly analogous results have recently been reported 
using trinitrophenyl  (tnp)-derivatized phosphatidyl  ethanol- 
amine, and anti-tnp antibodies (46).  Because glycolipids are 
not thought to span the lipid bilayer, Stern and Bretscher (45) 
concluded that capping of Forssman antigen, and therefore 
other membrane components must occur by a  mechanism 
not directly involving the microfilament system. As an alter- 
native explanation they proposed that membrane lipids are 
in a continual state of directed flow from a point of insertion 
to a  point of internalization,  and that aggregated molecules 
unable to  resist this  flow would  simply accumulate at one 
pole of the cell.  The hypothesis is partly based on the lipid 
insertion experiments, and is dependent on the assumption 
that such molecules do not become associated with membrane 
proteins that might then provide a link to the cytoskeleton. 
Since we  have now shown  that  capping of an endogenous 
glycolipid, ganglioside GM,, is accompanied by co-capping of 
a-actinin, it would be of interest to examine the distribution 
of cytoskeletal components during capping of inserted glyco- 
lipids (45,  47) and such studies are under way in our labora- 
tory. 
Finally, co-patching of cholera toxin-GMI complexes with 
a-actinin might be explained ifGM, were to be concentrated 
in microvilli, areas of the cell surface likely to be enriched in 
cytoskeletal components.  Indeed such a  nonuniform distri- 
bution of surface Ig has been described (48).  How such co- 
patching might be related to the development of surface caps 
with associated cytoskeletal material remains unclear. 
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